Profil
Johannes Weirather is the founder.
He founded Faire AG in 2021 and currently holds the title of Chief Executive Officer.
He previously worked at Synergy CHC Corp.
from 2017 to 2019 as the Chief Digital Officer-The Synergy Effect.
Mr. Weirather also worked as the General Manager at NomadChoice Pty Ltd.
Mr. Weirather graduated from the University of Innsbruck.
Postes actifs de Johannes Weirather
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Johannes Weirather
| Sociétés | Poste | Fin |
|---|---|---|
| SYNERGY CHC CORP. | Corporate Officer/Principal | 01/01/2019 |
NomadChoice Pty Ltd.
 NomadChoice Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Synergy CHC Corp., NomadChoice Pty Ltd. is an Australian company that offers tips and products for achieving a flat tummy, including detox teas, meal replacement protein shakes, and Apple Cider Vinegar Gummies. The company is based in Fremantle, Australia. Customers can receive a discount and cash rewards for referring others to the company. The company was founded by Andy Davies. NomadChoice was acquired by Synergy CHC Corp. on November 16, 2015 for $7.07 million. | Corporate Officer/Principal | - |
Formation de Johannes Weirather
| University of Innsbruck | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNERGY CHC CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
NomadChoice Pty Ltd.
NomadChoice Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Synergy CHC Corp., NomadChoice Pty Ltd. is an Australian company that offers tips and products for achieving a flat tummy, including detox teas, meal replacement protein shakes, and Apple Cider Vinegar Gummies. The company is based in Fremantle, Australia. Customers can receive a discount and cash rewards for referring others to the company. The company was founded by Andy Davies. NomadChoice was acquired by Synergy CHC Corp. on November 16, 2015 for $7.07 million. | Health Technology |
